Olistico Wealth LLC Trims Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Olistico Wealth LLC reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 4.6% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 579 shares of the healthcare conglomerate’s stock after selling 28 shares during the quarter. Olistico Wealth LLC’s holdings in UnitedHealth Group were worth $293,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. BlackBarn Capital Partners LP grew its holdings in UnitedHealth Group by 6.7% during the second quarter. BlackBarn Capital Partners LP now owns 32,000 shares of the healthcare conglomerate’s stock worth $16,296,000 after acquiring an additional 2,000 shares during the period. Insigneo Advisory Services LLC increased its holdings in shares of UnitedHealth Group by 9.0% in the 2nd quarter. Insigneo Advisory Services LLC now owns 10,890 shares of the healthcare conglomerate’s stock valued at $5,546,000 after purchasing an additional 897 shares in the last quarter. Lone Pine Capital LLC purchased a new stake in UnitedHealth Group during the second quarter worth about $480,903,000. Fred Alger Management LLC increased its holdings in UnitedHealth Group by 16.7% in the second quarter. Fred Alger Management LLC now owns 103,957 shares of the healthcare conglomerate’s stock valued at $52,941,000 after buying an additional 14,880 shares in the last quarter. Finally, Point72 Hong Kong Ltd boosted its stake in shares of UnitedHealth Group by 11.2% during the 2nd quarter. Point72 Hong Kong Ltd now owns 22,069 shares of the healthcare conglomerate’s stock worth $11,239,000 after acquiring an additional 2,221 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have commented on UNH shares. Truist Financial decreased their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Cantor Fitzgerald restated an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Barclays lowered their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. Piper Sandler lowered their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Finally, Royal Bank of Canada reduced their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 16th. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $627.74.

UnitedHealth Group Trading Down 1.1 %

Shares of UNH opened at $519.08 on Thursday. The stock’s fifty day simple moving average is $545.26 and its 200 day simple moving average is $564.10. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $477.70 billion, a P/E ratio of 33.49, a price-to-earnings-growth ratio of 1.42 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the prior year, the company earned $5.83 EPS. The company’s revenue was up 6.8% on a year-over-year basis. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.75 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.62%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.